SPIA
IMMX icon

Steward Partners Investment Advisory’s Immix Biopharma IMMX Stock Holding History

Steward Partners Investment Advisory’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,492
Closed -$2.22K – 4026
2024
Q3 		$2.22K Hold
1,492
– – ﹤0.01% 3420
2024
Q2 		$2.95K Hold
1,492
– – ﹤0.01% 3195
2024
Q1 		$4.58K Buy
+1,492
New +$5.78K ﹤0.01% 3073

Other funds holding IMMX

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Steward Partners Investment Advisory's IMMX Position: Q4 2024 in Review

Steward Partners Investment Advisory sold out of Immix Biopharma (IMMX) in Q4 2024, closing a stake of 1,492 shares — an estimated $2.22K sold.

Steward Partners Investment Advisory first reported a position in IMMX in Q1 2024 and held it in 3 quarters. The position peaked at $4.58K in Q1 2024. 23 funds tracked by Wall St. Rank hold IMMX as of Q4 2024.

  • Steward Partners Investment Advisory reported no remaining Immix Biopharma position as of Q4 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,492 Immix Biopharma shares in Q4 2024, an estimated $2.22K.
  • Steward Partners Investment Advisory first reported a position in Immix Biopharma in Q1 2024 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Immix Biopharma position peaked at $4.58K in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Immix Biopharma as of Q4 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2024, filed 6 Feb 2025.